Holly M. Robb

eIF2B activator prevents neurological defects caused by a chronic integrated stress response

Yao Liang Wong, Lauren LeBon, Ana M. Basso et al. · eLife · 2019 · 214 citations · Full text

Clinical Neuroscience, Neuroinflammation, Neurological Defects +18

Broad-Spectrum Efficacy across Cognitive Domains by α7 Nicotinic Acetylcholine Receptor Agonism Correlates with Activation of ERK1/2 and CREB Phosphorylation Pathways

Robert S. Bitner, William H. Bunnelle, David J. Anderson et al. · Journal of Neuroscience · 2007 · 185 citations · Full text

Neuropsychology, Synaptic Transmission, Neurotransmitter +21

Preclinical Characterization of A-582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition-Enhancing Properties

Karin Tietje, David J. Anderson, Robert S. Bitner et al. · CNS Neuroscience & Therapeutics · 2008 · 64 citations

α7 Nachrs, Synaptic Transmission, Neurotransmitter +20

Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor

Ramin Faghih, Sujatha M. Gopalakrishnan, Jens Halvard Grønlien et al. · Journal of Medicinal Chemistry · 2009 · 53 citations · Full text

Pharmacological Properties and Procognitive Effects of ABT-288, a Potent and Selective Histamine H3 Receptor Antagonist

Timothy A. Esbenshade, Kaitlin E. Browman, Thomas R. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 50 citations